Santos da Silva Jorge

Track

Insider profile

Performance

Overall performance
1.8
Performance over holding periods
1.8
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 52% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Santos da Silva Jorge's trades of MoonLake Immunotherapeutics's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-13 2026-07-10
PlS Planned sale
63,228 -31.8%
407.87
US$3,016,160 		63,228 -31.8% 407.87 US$3,016,160
2026-07-13 2026-07-09
PlS Planned sale
39,209 -29.9%
486.79
US$3,721,527 		39,209 -29.9% 486.79 US$3,721,527
2026-07-02 2026-07-01
PlS Planned sale
27,773 -12.2%
182.23
US$446,421 		27,773 -12.2% 182.23 US$446,421
2026-06-30 2026-06-30
PrS Proposed sale
150,000
20.03
US$3,004,500 		150,000 20.03 US$3,004,500
2026-04-14 2026-04-13
S Sale
51,873 -1.7%
18.23
US$945,645 		51,873 -1.7% 18.23 US$945,645
2026-04-14 2026-04-10
S Sale
98,127 -3.2%
18.41
US$1,806,518 		98,127 -3.2% 18.41 US$1,806,518
2026-04-10 2026-04-10
PrS Proposed sale
150,000
18.58
US$2,787,000 		150,000 18.58 US$2,787,000
2025-12-10 2025-12-09
S Sale
70,000 -2.4%
14.49
US$1,014,300 		70,000 -2.4% 14.49 US$1,014,300
2025-12-10 2025-12-08
S Sale
130,000 -4.2%
15.08
US$1,960,400 		130,000 -4.2% 15.08 US$1,960,400
2025-12-08 2025-12-08
PrS Proposed sale
200,000
14.90
US$2,980,000 		200,000 14.90 US$2,980,000
2024-02-29 2024-02-29
PlS Planned sale
4,740 -0.2%
55.89
US$264,919 		4,740 -0.2% 55.89 US$264,919
2024-02-29 2024-02-28
PlS Planned sale
56,065 -1.8%
55.00
US$3,083,575 		56,065 -1.8% 55.00 US$3,083,575
2024-02-29 2024-02-27
PlS Planned sale
62,810 -2.0%
55.00
US$3,454,550 		62,810 -2.0% 55.00 US$3,454,550
2024-02-23 2024-02-21
PlS Planned sale
1,125 -0.0%
55.27
US$62,179 		1,125 -0.0% 55.27 US$62,179
2024-02-20 2024-02-20
PlS Planned sale
20,000 -0.6%
57.44
US$1,148,800 		20,000 -0.6% 57.44 US$1,148,800
2024-02-20 2024-02-16
PlS Planned sale
20,000 -0.6%
60.15
US$1,203,000 		20,000 -0.6% 60.15 US$1,203,000
2024-02-20 2024-02-15
PlS Planned sale
20,000 -0.6%
60.18
US$1,203,600 		20,000 -0.6% 60.18 US$1,203,600
2024-02-15 2024-02-15
PrS Proposed sale
200,000
63.95
US$12,790,000 		200,000 63.95 US$12,790,000